14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRDF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Cardiff Oncology Inc. stock after gaining 0.240%
(Updated on Apr 24, 2024)

Sell candidate since Apr 16, 2024 Loss -8.93% PDF

The Cardiff Oncology Inc. stock price gained 0.240% on the last trading day (Wednesday, 24th Apr 2024), rising from $4.17 to $4.18. During the last trading day the stock fluctuated 7.09% from a day low at $4.09 to a day high of $4.38. The price has fallen in 8 of the last 10 days and is down by -29.03% for this period. Volume fell on the last day by -382 thousand shares and in total, 317 thousand shares were bought and sold for approximately $1.32 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to rise 187.00% during the next 3 months and, with a 90% probability hold a price between $12.00 and $21.77 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRDF Signals & Forecast

There are few to no technical positive signals at the moment. The Cardiff Oncology Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.36 and $5.05. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 25, 2024, and so far it has fallen -29.27%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Cardiff Oncology Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.89 and $3.65. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cardiff Oncology Inc. finds support just below today's level at $3.89. If this is broken, then the next support from accumulated volume will be at $3.65 and $3.49.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.290 between high and low, or 7.09%. For the last week the stock has had daily average volatility of 6.81%.

Cardiff Oncology Inc. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRDF) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Cardiff Oncology Inc. to open at $4.22, and during the day (based on 14 day Average True Range), to move between $3.64 and $4.72, which gives a possible trading interval of +/-$0.538 (+/-12.86%) up or down from last closing price. If Cardiff Oncology Inc. takes out the full calculated possible swing range there will be an estimated 25.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.89 (6.94%) than the resistance at $4.59 (9.81%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Cardiff Oncology Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.250. We will update the financials statements for Cardiff Oncology Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.36% in the first trading day after earnings release.

Is Cardiff Oncology Inc. stock A Buy?

The Cardiff Oncology Inc. stock holds several negative signals and despite the positive trend, we believe Cardiff Oncology Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.088 Sell Candidate Unchanged

Predicted Opening Price for Cardiff Oncology Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$4.22 ( 0.88%) $4.18

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRDF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.51 7.81 %
R2 4.40 5.16 %
R1 4.33 3.53 %
Current price: 4.18
Support S1 4.11 -1.77 %
S2 4.04 -3.41 %
S3 3.93 -6.06 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.17 23.68 %
R2 5.03 20.33 %
R1 4.59 9.81 %
Current price 4.18
Support S1 3.89 -6.94%
S2 3.65 -12.68%
S3 3.49 -16.51%

FAQ

What is the symbol for Cardiff Oncology Inc. Stock and on which exchange is it traded?
The symbol for Cardiff Oncology Inc. is CRDF and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cardiff Oncology Inc. Stock?
The Cardiff Oncology Inc. stock holds several negative signals and despite the positive trend, we believe Cardiff Oncology Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Cardiff Oncology Inc. Stock?
Cardiff Oncology Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cardiff Oncology Inc. Stock.

What's the current price of Cardiff Oncology Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Cardiff Oncology Inc. (CRDF) share was $4.18.

What is the 52-week high and low for Cardiff Oncology Inc. Stock?
The 52-week high for Cardiff Oncology Inc. Stock is $6.42 and the 52-week low is $0.94.

What is the market capitalization of Cardiff Oncology Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Cardiff Oncology Inc. is 186.304M.

When is the next earnings date for Cardiff Oncology Inc.?
The upcoming earnings date for Cardiff Oncology Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Cardiff Oncology Inc.

Cardiff Oncology. Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac... CRDF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT